Literature DB >> 34982395

Downregulation of Bdnf Expression in Adult Mice Causes Body Weight Gain.

Toru Suzuki1, Kenji F Tanaka2.   

Abstract

Gain or loss of appetite and resulting body weight changes are commonly observed in major depressive disorders (MDDs). Brain-derived neurotrophic factor (BDNF) is broadly expressed in the brain and is thought to play a role in the pathophysiology of MDDs and obesity. Congenital loss of function of BDNF causes weight gain in both humans and rodents; however, it is not clear whether acquired loss of function of BDNF also affects body weight. Thus, we exploited mutant mice in which the Bdnf expression level is regulated by the tetracycline-dependent transcriptional silencer (tTS)-tetracycline operator sequence (tetO) system. Time-controlled Bdnf expression using this system allowed us to establish congenital and acquired loss of function of Bdnf in mice. We demonstrated that changes in Bdnf expression influenced body weight during not only the developmental stage but also the adult stage of mice. Although it is still unclear whether acquired Bdnf loss of function in rodents mimics the pathology of MDD, our findings may bridge the mechanistic gap between MDDs and body weight gain in line with BDNF dysfunction.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bdnf isoforms; Body weight gain; Doxycycline; Isoform-specific Bdnf loss-of-function; Tetracycline-controlled transcriptional silencer; Time-controlled Bdnf loss-of-function

Mesh:

Substances:

Year:  2022        PMID: 34982395     DOI: 10.1007/s11064-021-03523-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  55 in total

1.  Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.

Authors:  B Chen; D Dowlatshahi; G M MacQueen; J F Wang; L T Young
Journal:  Biol Psychiatry       Date:  2001-08-15       Impact factor: 13.382

Review 2.  Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.

Authors:  Kenji Hashimoto
Journal:  Psychiatry Clin Neurosci       Date:  2010-08       Impact factor: 5.188

Review 3.  BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.

Authors:  Maryna Polyakova; Katharina Stuke; Katharina Schuemberg; Karsten Mueller; Peter Schoenknecht; Matthias L Schroeter
Journal:  J Affect Disord       Date:  2014-11-29       Impact factor: 4.839

4.  Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

Authors:  Félicien Karege; Guillaume Perret; Guido Bondolfi; Michèle Schwald; Gilles Bertschy; Jean-Michel Aubry
Journal:  Psychiatry Res       Date:  2002-03-15       Impact factor: 3.222

5.  Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.

Authors:  Félicien Karege; Geneviève Vaudan; Michèle Schwald; Nader Perroud; Romano La Harpe
Journal:  Brain Res Mol Brain Res       Date:  2005-03-05

6.  Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model.

Authors:  A Russo-Neustadt; T Ha; R Ramirez; J P Kesslak
Journal:  Behav Brain Res       Date:  2001-04-08       Impact factor: 3.332

7.  Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.

Authors:  Eiji Shimizu; Kenji Hashimoto; Naoe Okamura; Kaori Koike; Naoya Komatsu; Chikara Kumakiri; Michiko Nakazato; Hiroyuki Watanabe; Naoyuki Shinoda; Sin-ichi Okada; Masaomi Iyo
Journal:  Biol Psychiatry       Date:  2003-07-01       Impact factor: 13.382

8.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

9.  Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis.

Authors:  B Yang; Q Ren; J-C Zhang; Q-X Chen; K Hashimoto
Journal:  Transl Psychiatry       Date:  2017-05-16       Impact factor: 6.222

10.  Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders.

Authors:  M T Ray; C Shannon Weickert; M J Webster
Journal:  Transl Psychiatry       Date:  2014-05-06       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.